Nature Communications (Sep 2018)

Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer

  • Carolina Moretto Carnielli,
  • Carolina Carneiro Soares Macedo,
  • Tatiane De Rossi,
  • Daniela Campos Granato,
  • César Rivera,
  • Romênia Ramos Domingues,
  • Bianca Alves Pauletti,
  • Sami Yokoo,
  • Henry Heberle,
  • Ariane Fidelis Busso-Lopes,
  • Nilva Karla Cervigne,
  • Iris Sawazaki-Calone,
  • Gabriela Vaz Meirelles,
  • Fábio Albuquerque Marchi,
  • Guilherme Pimentel Telles,
  • Rosane Minghim,
  • Ana Carolina Prado Ribeiro,
  • Thaís Bianca Brandão,
  • Gilberto de Castro,
  • Wilfredo Alejandro González-Arriagada,
  • Alexandre Gomes,
  • Fabio Penteado,
  • Alan Roger Santos-Silva,
  • Márcio Ajudarte Lopes,
  • Priscila Campioni Rodrigues,
  • Elias Sundquist,
  • Tuula Salo,
  • Sabrina Daniela da Silva,
  • Moulay A. Alaoui-Jamali,
  • Edgard Graner,
  • Jay W. Fox,
  • Ricardo Della Coletta,
  • Adriana Franco Paes Leme

DOI
https://doi.org/10.1038/s41467-018-05696-2
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 17

Abstract

Read online

Oral cancer has region-specific histopathological and molecular characteristics, complicating its classification by the standard tumor-node-metastasis system. Here, the authors combine discovery and targeted proteomics with IHC to identify region-specific and saliva biomarkers for oral cancer prognosis.